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Summary.-Direct comparison of skin-tumour induction by 15,16-dihydro-11-
methylcyclopenta[a]phenanthren-17-one (1) and by benzo[a]pyrene on mouse skin,
bothbyrepeated application or by initiation with asingle dose followed bypromotion
with croton oil, demonstrated that these two carcinogens have similar potency. After
repeated application of (1) the mean latent period for skin-tumour induction was
linearly related to the logarithm of the dose over a 10-fold dose range. Under these
conditions, application of the aryl-hydrocarbon-hydroxylase inhibitor 7,8-benzo-
flavone together with (1) inhibited tumour induction by about 40%. By contrast, in
the2-stage experiment, little effect on tumour incidence or latentperiod was observed
when this inhibitor was applied with the single initiating dose of(1). Co-administra-
tion of the epoxide-hydratase inhibitor 1,1,1-trichloropropene oxide caused enhance
-
ment by shortening the latent period.
After s.c. injection of (1) into mice, a similar number of tumours was induced on
skin remote from the site ofinjection by promotion with croton oil begun either one
week or 6 months after initiation. Gastric instillation of (1) into female rats induced
mammary adenocarcinomas.
WE HAVE PREVIOUSLY OUTLINED our
interest in compounds of the cyclopeiita-
[a]phenanthrene series as aromatic ana-
logues of steroids (Coombs & Croft, 1969).
Comparisons of the carcinogenicity of
some 40 closely related members of this
series have revealed that the title com-
pound (1) (see Fig. 1) is the most active,
and that its activity depends upon 2
structural features: the presence of a small
electron-releasing group at C-11, and
further coniuLyation of the phenanthrene
ring system at C-17. Of the monomethyl
isomers, only the 11-methyl-17-ketone
(1) is strongly carcinogenic; the 7-methyl-
17-ketone is a weak carcinogen whilst the
2-. 3-. 4-. 6- , and 12-methyl isomers are
inactive, as is the unsubstituted parent
ketone (V) (Coombs et al., 1973). The
11-methoxy-17-ketone (11) is almost as
active as (1), but other methoxy isomers
lack activity. Strong careiiiogeiiicity is
also associated with the 11.,17-dimethyl-
16(17)-ene (111), in which conjugation
by the 17-carbonyl group is replaced by
conjugation by the 16(17)-double bond;
the corresponding hydrocarbon with a
saturated 5-membered ring is much less
active, as are ring-methyl isomers of
(111) (Coombs & Croft, 1969).
These comparisons were all made by the
same method: groups of 20 mice were
treated topically with 50 /-tg of the com-
pound twice weekly for one year, and
observed for a second year. First appear-
ance ofskin tumours at the site ofapplica-
tion (dorsal region) was scored, and
tumours were subsequently classified his-
tologically. In this paper, the carcino-
genicity of(1) is compared with that ofthe
classical carcinogen benzo[a]pyrene, both
by this method and by the 2-stage system.
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'I'he original method is also used to test
the 1,2,3,4-t,etrahydro derivative JV) for
carcinogenicity, and to investigate the
effect of the dose of (1) on latent period.
The effects of the enzyme modifiers 7,8-
benzoflavone (BF) and 1,1,1-trichloro-
propene oxide (TCPO) on its carcino-
genicity arepresented, as is theproduction
of mammary tumours in rat-feeding ex-
periments with (1).
MATERIALS AND METHODS
Che,tiiica18. The cvclopenta [a]pheiiaii-
threnes (1), JV) and (V) Nvere synthesized
here, as already described (Coombs, 1966;
Coombs & Bhatt, 1973); their structures are
shown in Fig. 1. Benzo[a]pyrene, 7,8-benzo-
400 /ig of cai-cinogeii hi 80 .ul of toluene: in
addition, mice in Group 13 each received BF
(1,200 .ug) dissolved in the carcinogen solu-
tion. T-,A-ice-weekly promotion with crotoii
oil (10 )ul of a I0/' v/v solution in toluene) as
indicated in the Table was begun 8 days later.
Animals in Group 14 -%i.ere treated topically
with TCPO (10 .ul of a 10% v/v solution in
toluene) at 30 min before and again imme-
diately before the initiating dose of carcino-
gen. Negative control Groups 17 and 18 -xN,ere
each treated initially with toluene (800 .ul);
mice in Group 17 were subsequently treated
twice -%i,eekly with this solvent (10 tti),
whereas those in Group 18 were "pi-omoted"
NN-ith croton oil in the usual %N,ay.
Mice in Groups 19-23 (Table 111) -%.,ere
injected, each in the right shoulder with the
carcinogen (1) in olive oil (0-2 ml); Groups
24 and 25 were similarly injected -%6th the
ketone (V) (3 mg), while Group 26 Ai-as iii-
jected '",ith olive oil alone. Promotion of the
shaved dorsal region as already describedwas
started 8 da s later (Groups 20, 22, and 25)
and 6 months later (Groups 21 and 23). In
all cases promotioii was continued for the
whole experiment, up to 2 years.
Animals -%..,ere killed when their skin tumout-
i-eached I cm indiameter; a few sick mice -%A-ere
killed earlier to avoid loss of material. All
animals were opened and examined macro-
scopically for abnormal tissues; tumours
other than those appearing on promoted skiii
for mice injected with (1) (Groups 19-21) are
shown in Table IV. All tumours -,%-ere exam-
ined histologically except in a fe-,N. cases, as
noted in the Tables, when they were unavail-
able because the animal had died, and auto-
lysis was too faradvanced, andalsoNN-hen more
than one skin tuniour per animal was ob-
tained. In the latter case only the first-
appearing tumour, which was usually also
the first to reach I cm in diameter, -,.,as
examined histologically. Classification of
skin tumours as papillomas or carcinomas
was carried out as previously described
(Coombs et al., 1973). Usually lcm tumours,
were carcinomas when induced by repeated
application of the carcinouen (Table 1), but
papillomas were more common -,ihen pro-
duced by initiation and promotion (Tables
11 and 111). A complete list of experimental
and control groups appears in Tables 1-111,
'"7hich also show the rate of tumourless sur-
vival.
Rat experintent.-Virgin Sprague-Dawley
0
CH30
11
120
11
1 6
z
3 7
4 6
'V
Fi(.,. I.-Structures ofcyclopenta[a]phenan-
threnes mentione(t in the text.
flavone and I I1,I-trichloropropene oxide were
obtained from the Aldrich Chemical Co.,
Milwaukee, and croton oil from the Sigma Chemical Co., St Louis. Toluene was Analar
grade from Fisons Ltd., Loughborough, and
was used throughout as the vehicle.
Mouse experiments.-Formally randomized
TO (Tyler's Original) albino mice (10 males
and 10 females) were used for each group, 1-3 and 6-26; Groups 4 and 5 each consisted
of 20 males and 20 females. Conditions were
generally as previously described (Cooinbs &
Croft, 1969).
In Groups 1-10 (Table 1) compounds, or
mixtures were applied to the shaved dorsal
skin twice weekly as toluene solutions (10 jil
at each administration) for 50weeks, and the
inice were observed for up to 100weeks. Mice
in Groups 11-16 (Table 11) each received
CH
CH3
0
CH
I
0
CH3
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rats, random-bred in this Institute, were
divided into 2 groups by a formal randomiza-
tion procedure. They were housed 3-4 to a
cage, fed on pelleted GR 3 diet (Dixon and
Son, Ware, Herts) and allowed free access to
water. At 50 days ofage, 30 mg ofcarcinogen
(1), suspended and partly dissolved in corn
oil (2 ml), was given intragastrically to each
of 27 rats; a further 96 rats were left un-
treated. From the fourth week of treatment
all rats were examined weekly to detect
developing tumours. These were removed
surgically whenthey had grown to about I cm
in diameter, and were classified histologically
(Table V) as malignant adenocareinomas or
benign fibroadenomas (Young & Hallowes,
1973).
Statistical method8.-Latent periods shown
in Figs. 2-4 refer to the first appearance of
the first skin tumour on each animal. Mean
latent periods are listed in Tables 1-111
together with their standard deviations.
Estimation oftheprobability ofthe curves of
latent period for Groups 4 and 5, 12 and 13,
and 12 and 14 (Figs. 2 and3) being different is
made by the summary chi-square procedure
advocated by Mantel (1966) for comparing
2 sets of life tables in their entiretv. This
statistical method takes both differences in
latent period and tumour incidence into con-
sideration overthe wholeexperimentalperiod,
rather than at anysingle time. The test tends
to be conservative, in that the latent periods
are considered only as the order in which the
first tumour on each animal appears in time,
and not as actual time values. The probabili-
ties of the number of rat mammary tumours
being significant (Table V) are calculated by the exact method ofYates (Fisher, 1954).
RESULTS
Direct comparison of the tumour inci-
dence and mean latent period of skin
tumours produced by the carcinogen (1)
at its lowest dose (Group 4, 34.7 weeks,
45%) with benzo[a]pyrene at the same
dose (Group 8, 37-5 weeks, 50%) (Fig. 2) demonstrates that they are similar as
complete carcinogens on mouse skin. Also
shown in Fig. 2 are curves formed by plotting the time of first appearance of
skin tumours with (1) at 50, 25, 10, and
ntto,twice weekly. Using the well known
.Ijoe- LATENT
J I
20 30 40 50 60 30 40
LATENT PERIOD (weeks) PERIOD
Fic.. 2.-Induction of dorsal skin tumours in
mice by twice-weekly application of benzo-
[a]pyrene (+ +) and the ketone (1)
(0-0) at doses stated. Tumoursproduced
with (1) (5 jug) together with 7,8-benzo-
flavone (15 pg) are shown by solid circles
(0-0). For this and Figs. 3 and 4,
"latent period" means times from begin-
ning of treatment.
empiricalrelationship between mean latent
period (L, in weeks) and dose (d, in pg),
L = a b (loglo d +c),
where a, b, and c are constants (Bryan &
Shimkin, 1941), the plot of L against
-logiod approximates to the straight
line , and the mean latent period
= 29
-40-
10-803(loglod 1-199) with a correlation
coefficient, r = 0
-96. Also shown are the
6 tumours induced by twice-weekly appli-
cations of (1) (5 jug) plus 7,8-benzoflavone
(I5 pg), with a mean latent period of
36-2 weeks. When this latent period is
fitted on an extrapolation of the dose-
response curve, it appears that under these
conditions the inhibitoreffectively reduces
the administered dose to about 3 pg. Finally, Table I shows no evidence for
carcinogenicity for the 1,2,3,4-tetrahydro derivative (IV) in this test involving re-
peated applications.
Fig. 3 and Table 11 illustrate the results
of the initiation-promotion experiments. A single application of 400 /-kg of (1) per
mouse followed by twice-weekly promo-
tion with croton oil (Group 12, 30.0 weeks,
1-5-
1.0
0-5-
r,
0
.51
CD
0
0
U)
m
0
ft
;K90%) gave a result similar to that, ob-
served recently (Coombs & Bhatt, 1978)
when the initiating dose was subdivided
andgiven on 4 subsequentdays (35 weeks,
90%). Comparison of Groups 12 and 16
reveals that (1) is somewhat more active
thanbenzo[a]pyrene as an initiator (Group
161 33 weeks, 65%). Both carcinogens at
this dose gave some skin tumours without
I TC1110
F
u) -15 promoted
0 BaP 2 +
D
+/
F- 10 +
w
+ BaP
+ +
0
ir -5 not
m promoted
D
z
I - I
. r%
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TABLE I.-Skin-tumourproduction in mice by repeated topical application
.Xo. of turnour-free
survivors at
(months)
6 12 18 20
8 1
15 0 0 0
18 2 1 0
37 1 8 12 6
38 31 20 8
19 18 12 5
20 20 1 3 6
16 9 5 0
is 14 9 3
1 9 18 1 0 4
No. of
MICle
with
ttimours
17
is
16
18*
6
0
0
10*
No. of squamous
papil- carci-
lomas nomas
0 17
2 16
1 15
3 13
:3 3
Alean
latent
period +
s.d.
23-3 + 8-1
28-4 + 7-7
31-2 + 6-8
34-7 + 8-2t
36-2 + 8-6t
Dose
(ttg, 2 x
week)
50
25
W
5
5+ 15
15
50
5
Groul)
I
3
4
5
6
7
8
9
10
Compound(s)
I
I
I
I
I+BF
BF
IV
B[a]P
toluene
:3 5 37-5+ I I--2
* Txvo tumotit-s were uiiax-allable foi- Iiistology in eacli ofGroups 4, and 8.
P 4 v-9 5 < 0-01, estimated by the metlio(i of Alantel (1966)-see Materials an(i Aletlio(is.
promotion (Groups I I and 15) after coni-
paratively long latent periods.
Unexpectedly, topical application of
7,8-benzoflavone (1,200 fkg/mouse) to-
gether with the initiating dose (400 [kg)
of(1) (Group 13) appears to have no effect
on latent period or tumour incidence. This
is in marked contrast to the result with
repeated twice-weekly administration, al-
ready discussed. Application of the
epoxide-hydratase inhibitor TCPO before
theinitiating dose of(1) (Group 14) caused
enhancement, evident as shortening of the
latent period.
After i.m. injection of (1) (3 mg/
mouse), this carcinogen initiated skin
tumours remote from the site ofinjection.
As shown in Fig. 4 and Table 111, promo-
tion by croton oil started 8 days after
initiation led to skin tumours in 65% of
the mice, with a mean latent period of 33
weeks (Group 20). When promotion was
delayed for 6 months, 50% of the mice
developed skin tumours, with a mean
latent period of 24 weeks from the start of
croton-oil treatment (Group 21). No
tumours appeared on the dorsal skin
without promotion (Group 19); however,
other tumours were found in animals of
all 3 groups (Table IV). Injection of 300 tkg
of (1) (Groups 22 and 23) was ineffective,
as was injection of 3 mg of the unsubsti-
tuted ketone (V) (Groups 24 and 25,
Table 111).
Mammary adenocarcinomas wei-e de-
10 20 30 40 50 60
LATENT PERIOD (weeks)
FiG. 3.-Induction of (lorsal skin tumours in
miee in the two-stage system. Initiation,"ras
wiith 400 tLg of benzo[a]pyrene
ketone (1) (0-0), ketone (1) plus 7,8-
benzoflavone (1-2 mg) (0-0), or ketone
(1)+TCPO (see text) ((.-O+). Promote(i
with croton oil, or not, as shown.I I I I I I
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TABLE II.-Skin-tumourproduction in mice in the initiation-promotion experititents
iNleaii
o. of squamous latent,
perio(t
papil- carcl- + s.d.
lomas nornas (weeks)
4 1 46-0 + 10-7
13 3 29-9 + 13-9
12 4 30-6+9-5§
16 23-6+9-7§
5 2 42-9 + 17-7
9 3 33-5 + 17-:3
motioii Pror
(t,
we
Cill
No. of tumour-free
No. of
mice
witli
tumours
5
18t*
1 6
19*
7
13*
0
'wice survivors at
E.ekly (montlis)
-otori r
oil) 6 12 18
18 17 10
+ 12 5 1
+ 15 1 1
+ 9 2 1
19 15 12
24
6
0
10
4
7
5
Compound(s)+
I
I
I+BF
1 +TCPO
B[a]P
B[a]P
toluene
toluene
GI-oup
I 1
12
13
14
15
16
17
18
14
20
19
13
18
is
4
1 6
15
* Histology unavailable for oiie aiiii-nal.
t One tumour was a spin(ile-cell sarcoma.
+ The initiating dose of (1) an(I B[a]P was 400 tLg/motise; in Grotip 1:3, 7,8-benzotlavone (BF) (1,200 ttgl
mouse) applied simultaneously; mice 'n Group 14 receive(i 1,1,1-tr'cliloropropene oxide (TCPO) (10 jil 1 1
of a 100// v/v solution) at 30 min before and again immediately before tlle initiating (lose of (1).
P12 vs 13=0-62;PI2 vs 14=0-17, estimatedby the method ofMantel (1966)-see Materials and Methods.
contrast, benign fibroadenomas occurred
later, and to a similar extent in both
groups.
DISCUSSION
In both the repeated-applicatioii and
initiation-promotion experiments 15,16-
dihydro-.11-methyleyclopenta[a] phenan-
thren-1.7-one (1) is comparable with benzo-
[a]pyrene as a carcinogen, despite the
former having only 3 fused aromatic
rings. Practically all known carcinogenic
polycyclic hydrocarbons have 4 or more
fused aromatic rings, 3 of which form a
phenanthrene ring system. The ketone
(1), in common with a number of other
phenanthrene-derived carcinogens (Jerina
et al., 1978) is metabolically activated by
conversion to its bay-region, 3,4-dihydro-
3 .4 dihydroxy 1,2 dihydro 1,2 epoxide
(Coombs et al., 1979). It therefore seems
probable that (1) represents the smallest
conjugated system that can be activated
by this mechanism to display strong car-
cinogenic activity. No evidence for car-
cinogenicity was found for its 1,2,3,4-
tetrahydro derivative (IV), in keeping
with the proposed activation mechanism,
for this compound lacks the necessary
double bonds for metabolic formation of a
bay-regiondiol-epoxide.
At the lowest dose (5 /ig twice weekly)
co-administration ofthearyl-hydrocarbon-
-15
Gp 20
10
- Gp21
5
(n
w
Z)
0
2
Z)
1--
-r
1--
3::
w
M:
LL.
0
w
w
m
2
Z)
Z
10 20 30 40 50
LATENT PERIOD (weeks)
60
Fic.. 4.-Induction of dorsal skin tumours
after injection of tite ketone (1) (3 mg/
mouse) followed by promotion witli croton
oil 8 days (0-0), or 6 montlis (0-0)
later.
tected during the 18th week after intra-
gastric treatment of rats with 30 mg ofthe
carcinogen (1), but the single spontaneous
tumour did not appear in the untreated
group until the 42nd week. Differences in
tumour incidence between the two groups
was significant at 20 weeks and highly
significant at 50 weeks (Table V). ByCARCINOGENESIS BY A CYCLOPENTA[A]PHENANTHRENE 919
TABLE III.-Skin tumoursappearing onpromoted 8kinfollowinginjectionof(I) into mice
Promotion
(twice
weekly
croton
oil)
none
8days later
6 months later
8days later
6 months later
none
8days later
none
No. of
mice
with
dorsal
tumours
0
13
9
0
0
0
0
0
Mean
latent
period
+ s.d.
(weeks)
33+11-3
49* + 7-0
No. oftumour-free
survivors at (months)
--A
6 12 18 24
20 16 5 0
18 13 0 0
18 11 7 2
19 18 10 5
19 19 14 11
19 19 14 8
19 18 16 12
20 19 18 14
No. ofsquamotis
r
A
papil- carci-
lomas nomas
Injec-
ted
Com- dose
pound (mg)
1 3
1 3
1 3
1 0-3
I 0-3
v 3
v 3
olive oil
Group
19
20
21
22
23
24
25
26
9
8
4
1
* 24 weeks from beginning ofpromotion.
TABLE IV.-Tumours other than those appearing on promoted skin, after injection of (I)
into mice
Mice with
lung adenomast
4
7
8
Group Eyelid
19 4 (2 pa.)*
20 4 sq. pa.
2 anaplastic sq. ca.
I sebaceous adenoma
21 1 sq. pa.
I sq. ca.
Ear Head
2 sq. pa.
I sq. ca.
Ventral surface
2t (I mammary ca.)
I sq. pa.
I sq. ca. I sq. pa.
* Histology not available for 2 tumours.
t Histology not available for I tumour.
sq. pa.
=squamous papilloma.
sq. ca.=squamous carcinoma.
$ No lung adenomas among animals in the olive-oil control (Group 26).
TABLE V.-Mammary tumours induced in rat8 a er intraga8tric in8tillation of (I) ft
(30mglrat)
No. of rats
r-
A
No. of rats with
at time of tumour alive
treatment at 20 weeks
No. ofrats
r-
A
with
tumour alive
at 30 weeks
No. of rats
r- A
with
tumour alive
at 50 weeks
No. ofrats
11
with
tumour alive
at 75 weeks
Adenocareinomas
In rats after I
In untreated rats
P*
Fibroadenomas
In rats after I
In untreated rats
P*
27 2 26
96 0 94
0-455
27 0 26
96 0 94
4
0
0-0019
0
0
26 6
92 1
0.0001
20
85
0 20 2 13
3 85 7 70
0-5270 0-2845
26
92
* Exact value ofP calculated by method of Yates (Fisher, 1954).
hydroxylase inhibitor, 7,8-benzoflavone
(15 /-tg) reduced the carcinogenicity of (1),
in agreement with previous observations
(Coombs et al., 1975). Using the dose-
response curve shown in Fig. 2, BF
apparently causes about 40% inhibition
of tumour production under these condi-
tions. It was therefore surprising that
inhibition waslacking when BF (1,200 /-kg)
was given together with the initiating
dose of 1 (400 pg) in the two-stage experi-
ment. The reason for this difference is not
clear. Several workers have shown that
BF inhibits hydrocarbon-induced aryl920 M. M. COOMIIS. T. S. 13HATT AND S. YOUNCr
hydrocarbon hydroxylase more than the
constitutive enzyme (Grundin et al., 1,973
Hill & Shih5 1975; Wiebel et al., 1971).
It seems possible that promotion experi-
ments usino, a relatively large single dose,
as described here, might differ from experi-
ments in which a small dose is adminis-
tered repeatedly, in that, the majority of'
the dose would be activated by the con-
stitutive enzyme in the first situation, but
not in the second.
Shortening of the mean latent period
was obtained when the epoxide-hydratase
inhibitor TCPO was given topically to-
gether with the initiation dose of (1).
Enhancement, of tumotir production with
TCPO has also been reported for 3-
methylcholanthrene (Berry et al., 1977;
Burki et al. 5 1974) and benzo[alpyrene
(Berry et al., 1.977). With the latter, the
inhibitor in vitro preventshydration ofthe
initially formed 7,8-oxide to the 7,8-diol
(Selkirk et al., 1974) but the ultimate car-
cinogen, the 7,8-dihydroxy-9,10-epoxide,
is apparently not a substrate for this
enzyme (Wood etal., 1976). Thecarcinogen
(1) is activated in a manner analogous to
that of benzo[a]pyrene, so it seems prob-
able that the mechanism bv which TCPO
causes enhancement is the same in both
cases. Possibly, by inhibiting cytoplasmic
epoxide hydratase, TCPO allows the
initially-formed non-bay region oxide to
escape to a site where it can be more
advantageously further converted into the
ultimate carcinogen.
In the experiments so far described in-
volving topical application of (1), tumour
formation is confined to the treated skin.
The injection (mouse) and feeding (rat)
experiments demonstrate that this car-
cinoo,en is also active systemically, and
in more than one animal species. Pre-
viously, injection of (1) (8 and 50 mg) into
mice led to ventral skin tumours as well
as sarcomas at the site of injection
(Coombs & Croft, 1969). Tumours at
several sites, including the ventral sur-
faces, were seen in the present experiment
(Table IV). Injection of 3 mg per mouse,
btit not one tenth of this dose , was suffi-
cient to initiate the doi-sal skin (Fig. 4 aii(I
Table 111) so that s-Libsequent promotion
yielded a skin-tuniour incidence of 650/
and a mean latent period of 33 weeks."O
After injection initiation persisted, for
when promotion was started 6 months
later skin tumours occurred in 500/ of the
mice, but with a shorter mean latentperiod
of 24 weeks (calculated from the beginning
of promotion). No tumours were induced
with the parent tinsubstituted ketone (V)
when ii-ijection of this compound (3 mg)
was followed by topical treatment with
croton oil. This aorees with the failure to
induce tumours in mice by injection (50
mor) or by skin paintino, (.50 tLo, twice
weekly) (Coombs & Croft, 1969) or in the
two-stage system with an "initiating" dose
of 400 tkg (Coombs & Bhatt, 1,978).
In its ability to induce mammary car-
cinomas after a single intragastric instil-
lation of 30 mg, compound (1) resembles
other known potent carcinogens such as
3-methylcholant,hrene (Shay et al., 1949.)
and 7) 12 dimethylbenz ra] anthracene
(Huggins, 1961). However, it is less potent
than either ofthese, both in thisregard and
also as jtidged by their relative mean
latent periods for induction of skin
tumours in mice (Coombs & Croft, 1.969).
The suggestion that the carcinogenicity of
aromatic hydrocarbons increases as their
structure approaches that of the steroids
(Yang et al., 1.961) is therefore not sub-
stantiated. The ketone (1) not only pos-
sesses the same carbon-ring system as the
steroids, but also bears an oxygen atom
at C-17 , a position which is oxygenated in
virttially all natural C18 and C119 steroids.
This carcinogen, with potency similar to
that of benzora]pyrene, is best considered
as a simple member of the large group of
polycyclic hydrocarbon carcinogens whose
structures are based on phenanthrene.
Al'e. tliank Dr L. Paiig forcoiifirm'tig the patliology of ttie mouse tumours, Aliss J. Alacdonald for valu-
able assistance, and Mr G. D. Everitt for provid'trig
computer facilities.
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